Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
6
×
amgen
biotech
clinical trials
eli lilly
life sciences
national blog main
indiana blog main
indiana top stories
teva pharmaceutical
boston blog main
calcitonin gene-related peptide
chronic migraine
migraine
migraine research foundation
national
national top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
allergan
biohaven
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drugs
episodic migraine
eptinezumab
erenumab
fremanezumab
galcanezumab
indiana
lasmiditan
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
What
migraine
6
×
class
drug
fda
new
approval
won
medicines
approved
decades
developed
drugs
eli
lilly
medication
nod
pain
pharmaceutical
potential
starts
acute
addresses
adults
allergan
amgen
announced
arguments
bacteria
based
big
brand
candidates
causes
commercialized
companies
company
competitors
condition
decision
friday
Language
unset
Current search:
migraine
×
fda
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@slashgear.com
4 years ago
Popular migraine drug recalled over potentially serious bacteria risk
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines